Grassley slams secrecy in healthcare pricing
A Republican senator has criticised the lack of transparency on drug pricing in the US, arguing that the mystery behind price negotiations make it difficult for Congress and consumers to follow the money.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10